Brad Loncar

Brad Loncar is Chief Executive Officer of Loncar Investments LLC, a private biotech-focused family office and provider of stock market indices. He launched the LCINDX Index in March of 2015, and the Loncar Cancer Immunotherapy ETF (CNCR) listed on the NASDAQ stock market in October. Mr. Loncar regularly provides his unique insight and analysis on the biotechnology space to the investment community via a variety of publishing platforms. He previously worked in the financial services industry at Franklin Templeton Investments, and was appointed to serve in a Senior Adviser role at the U.S. Department of the Treasury.